ClinicalTrials.Veeva

Menu

Local Control After Robot-assisted Supraglottic Laryngectomy

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Supraglottic Squamous Cell Carcinoma

Treatments

Procedure: Transoral robotic surgery (TORS)

Study type

Observational

Funder types

Other

Identifiers

NCT03357107
CRC_GHN_2017_009

Details and patient eligibility

About

Transoral robotic surgery is an option to treat supraglottic squamous cell carcinomas. Oncological outcomes 2 years after transoral robotic surgery for supraglottic laryngectomy were studied.

Enrollment

122 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men or women over 18 years of age
  • Patients with supra-glottic squamous cell carcinoma from T1 to T3, all stages N
  • Patients with a robot assisted supra-glottic laryngectomy with at least 2 years follow-up

Exclusion criteria

  • Patients for whom follow-up of at least 2 years has not been achieved;
  • Major patients protected by the law (under guardianship or guardianship);
  • Patients who expressed opposition to their participation in the study.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems